Future Directions and Therapeutic Potential Looking ahead, GPx holds promise for therapies
Common synergistic combinations include: MOTS-c for metabolic function Tesamorelin for visceral fat KPV for inflammation What happens when I stop therapy
Hair loss is more than just a physical concern
Huang K, Chu Y, Qin X, Zhang J, Bai Y, Wang Y, Luo H, Huang H, Su X (2021) Recombinant production of two xylanase-somatostatin fusion proteins retaining somatostatin immunogenicity and xylanase activity in Pichia pastoris
DOI: 10.2337/dc16-1495 18
doi: 10.1016/j.celrep.2020.107768 79 Mietlicki-BaaseEGLiberiniCGWorkingerJLBonaccorsoRLBornerTReinerDJet al